Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Saint Laurent, Quebec, Canada
SEC filing record 1 source field available
Fiscal year end
31 December
Repare Therapeutics Inc. has filed 424 SEC EDGAR filings since 06 Apr 2020

SEC filing history

Showing 201-225 of 424 matching filings.

Per page
25
Current page
9
4

FORM 4 SUBMISSION

Filing date
16 May 2022
Reporting date
13 May 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
16 May 2022
Reporting date
13 May 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
16 May 2022
Reporting date
13 May 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
16 May 2022
Reporting date
13 May 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
16 May 2022
Reporting date
13 May 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
16 May 2022
Reporting date
13 May 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
16 May 2022
Reporting date
13 May 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
16 May 2022
Reporting date
13 May 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-257668

EFFECT filing

Filing date
25 Apr 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-39335

DEFA14A

Filing date
01 Apr 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-39335

DEF 14A

Filing date
01 Apr 2022
Reporting date
13 May 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
16 Mar 2022
Reporting date
15 Mar 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-263469

S-8

Filing date
11 Mar 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
POS AM File 333-257668

POS AM

Filing date
07 Mar 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
POS AM File 333-257668

POS AM

Filing date
02 Mar 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
POSASR File 333-257668

POSASR

Filing date
01 Mar 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-91542

SC 13G/A

Filing date
14 Feb 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-91542

SC 13G filing

Filing date
14 Feb 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-91542

SC 13G/A filing

Filing date
14 Feb 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-91542

AMENDMENT NO. 3 TO THE SCHEDULE 13G

Filing date
14 Feb 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .